Φορτώνει......
Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease
BACKGROUND: Inolimomab, a monoclonal antibody against IL-2Rα (CD25) has shown promising results in the treatment of steroid-resistant acute graft-versus-host disease (aGvHD). OBJECTIVE: Our purpose was to characterize its pharmacokinetic (PK) and pharmacodynamic (PD) properties in first line treatme...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Adis Intrnational Ltd
2007
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2760126/ https://ncbi.nlm.nih.gov/pubmed/17465640 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|